Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS DEFICIT (Tables)

v3.22.1
STOCKHOLDERS DEFICIT (Tables)
3 Months Ended
Mar. 31, 2022
REVENUE FROM CONTRACTS WITH CUSTOMERS  
Schedule of conversion of Series C Preferred stock

 

 

March 31,

2022

 

 

December 31,

2021

 

Estimated number of shares issuable for conversion at $3.25 per share

 

 

4,938,462

 

 

 

6,440,000

 

Estimated number of common shares required to satisfy Conversion Premium using VWAP at period end

 

 

118,707,797

 

 

 

103,226,626

 

 

 

 

123,646,259

 

 

 

109,666,626

 

Schedule of outstanding warrants

Warrants

 

 

Exercise

 

 

Expiration

 

lntrinsic Value at

 

Outstanding

 

 

Price ($)

 

 

Date

 

March 31, 2022

 

 

 

 

 

 

 

 

 

 

 

 

3

(1) 

 

$ 195,312.50

 

 

September 12, 2022

 

$ -

 

 

32

(2) 

 

$ 12,187.50

 

 

May 24, 2023

 

$ -

 

 

50,000,000

(3) 

 

$ 2.00

 

 

December 30, 2026

 

$ -

 

 

50,000,000

(3) 

 

$ 4.00

 

 

December 30, 2026

 

$ -

 

 

100,000

(4) 

 

$ 0.705

 

 

April 25, 2025

 

$ -

 

 

25,000,000

(5) 

 

 

10.00

 

 

December 31, 2026

 

$

 

 

 

25,000,000

(5) 

 

 

20.00

 

 

December 31, 2026

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

150,150,035

 

 

 

 

 

 

 

 

$ -